Login
Home
Charts
Search
Watchlist
Products

Akums Drugs & Pharmaceuticals Ltd

AKUMS·NSE
₹807.90-1.65%Tue, 22 Sept '26
Industry:Pharma - Formulators
Indices:

Akums Drugs & Pharmaceuticals Ltd

AKUMS
NSE
₹807.90
-1.65%
|Tue, 22 Sept '26
SOICxStockScans Reports
Industry
Pharma - Formulators
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹12,828Cr
Close
Close Price
₹815.00
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
42.78
PS
Price To Sales
2.85
Revenue
Revenue
₹4,502Cr
Rev Gr TTM
Revenue Growth TTM
9.18%
PAT Gr TTM
PAT Growth TTM
-15.71%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1,1811,0839441,0191,0331,0101,0561,0241,0181,1601,1581,167
Growth YoY
Revenue Growth YoY%
5.1-12.5-6.711.80.5-1.514.89.713.9
Expenses
ExpensesCr
1,0299899418919128899628959231,0131,006992
Operating Profit
Operating ProfitCr
1529331281211219412994147152175
OPM
OPM%
12.88.60.312.611.712.08.912.69.312.713.115.0
Other Income
Other IncomeCr
-21101071719262732163430
Interest Expense
Interest ExpenseCr
1412121312552323242425
Depreciation
DepreciationCr
303234343545403738404041
PBT
PBTCr
8759-33879291759666100121139
Tax
TaxCr
54-1367262525-743123324038
PAT
PATCr
33195-3961676615065436881101
Growth YoY
PAT Growth YoY%
132.7103.9-66.0479.15.7-35.92.0-45.656.1
NPM
NPM%
2.818.0-4.26.06.56.614.26.34.25.87.08.7
EPS
EPS₹
4.113.2-2.94.24.44.39.64.22.74.35.56.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1,1811,0839441,0191,0331,0101,0561,0241,0181,1601,1581,167
Growth YoY
Revenue Growth YoY%
5.1-12.5-6.711.80.5-1.514.89.713.9
Expenses
ExpensesCr
1,0299899418919128899628959231,0131,006992
Operating Profit
Operating ProfitCr
1529331281211219412994147152175
OPM
OPM%
12.88.60.312.611.712.08.912.69.312.713.115.0
Other Income
Other IncomeCr
-21101071719262732163430
Interest Expense
Interest ExpenseCr
1412121312552323242425
Depreciation
DepreciationCr
303234343545403738404041
PBT
PBTCr
8759-33879291759666100121139
Tax
TaxCr
54-1367262525-743123324038
PAT
PATCr
33195-3961676615065436881101
Growth YoY
PAT Growth YoY%
132.7103.9-66.0479.15.7-35.92.0-45.656.1
NPM
NPM%
2.818.0-4.26.06.56.614.26.34.25.87.08.7
EPS
EPS₹
4.113.2-2.94.24.44.39.64.22.74.35.56.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,4142,7233,6723,6554,1784,1184,3594,502
Growth
Revenue Growth%
12.834.9-0.514.3-1.45.89.2
Expenses
ExpensesCr
2,2402,4853,7643,3614,0553,6543,8373,934
Operating Profit
Operating ProfitCr
174237-92294123464522568
OPM
OPM%
7.28.7-2.58.02.911.312.012.6
Other Income
Other IncomeCr
26121015869109112
Interest Expense
Interest ExpenseCr
207174651359496
Depreciation
DepreciationCr
677095113126153155159
PBT
PBTCr
114172-193150-45345382426
Tax
TaxCr
70495852-461126133
PAT
PATCr
44123-251981344256293
Growth
PAT Growth%
182.8-303.2139.0-99.243,416.1-25.4-15.7
NPM
NPM%
1.84.5-6.82.70.08.35.96.5
EPS
EPS₹
357.08.6-17.66.6-0.322.616.719.1
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,4142,7233,6723,6554,1784,1184,3594,502
Growth
Revenue Growth%
12.834.9-0.514.3-1.45.89.2
Expenses
ExpensesCr
2,2402,4853,7643,3614,0553,6543,8373,934
Operating Profit
Operating ProfitCr
174237-92294123464522568
OPM
OPM%
7.28.7-2.58.02.911.312.012.6
Other Income
Other IncomeCr
26121015869109112
Interest Expense
Interest ExpenseCr
207174651359496
Depreciation
DepreciationCr
677095113126153155159
PBT
PBTCr
114172-193150-45345382426
Tax
TaxCr
70495852-461126133
PAT
PATCr
44123-251981344256293
Growth
PAT Growth%
182.8-303.2139.0-99.243,416.1-25.4-15.7
NPM
NPM%
1.84.5-6.82.70.08.35.96.5
EPS
EPS₹
357.08.6-17.66.6-0.322.616.719.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
111429293131
Reserves
ReservesCr
7218846086896813,0163,283
Current Liabilities
Current LiabilitiesCr
7305801,2721,2661,2118941,095
Non Current Liabilities
Non Current LiabilitiesCr
6277001,1711,2781,5851561,021
Total Liabilities
Total LiabilitiesCr
2,0782,1673,0693,2673,5164,1135,447
Current Assets
Current AssetsCr
1,2501,1571,8641,8791,9412,2753,560
Non Current Assets
Non Current AssetsCr
8281,0091,2051,3881,5751,8391,887
Total Assets
Total AssetsCr
2,0782,1673,0693,2673,5164,1135,447
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
111429293131
Reserves
ReservesCr
7218846086896813,0163,283
Current Liabilities
Current LiabilitiesCr
7305801,2721,2661,2118941,095
Non Current Liabilities
Non Current LiabilitiesCr
6277001,1711,2781,5851561,021
Total Liabilities
Total LiabilitiesCr
2,0782,1673,0693,2673,5164,1135,447
Current Assets
Current AssetsCr
1,2501,1571,8641,8791,9412,2753,560
Non Current Assets
Non Current AssetsCr
8281,0091,2051,3881,5751,8391,887
Total Assets
Total AssetsCr
2,0782,1673,0693,2673,5164,1135,447

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
28131321774984651,181
Investing Cash Flow
Investing Cash FlowCr
-190-109-235-305-330-548-930
Financing Cash Flow
Financing Cash FlowCr
233-91236125-1087334
Net Cash Flow
Net Cash FlowCr
71-7033-460-10285
Free Cash Flow
Free Cash FlowCr
-3449-224-110212201958
CFO To PAT
CFO To PAT%
64.5105.8-12.7180.663,070.8135.3460.7
CFO To EBITDA
CFO To EBITDA%
16.255.0-34.760.1405.1100.2226.3
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
28131321774984651,181
Investing Cash Flow
Investing Cash FlowCr
-190-109-235-305-330-548-930
Financing Cash Flow
Financing Cash FlowCr
233-91236125-1087334
Net Cash Flow
Net Cash FlowCr
71-7033-460-10285
Free Cash Flow
Free Cash FlowCr
-3449-224-110212201958
CFO To PAT
CFO To PAT%
64.5105.8-12.7180.663,070.8135.3460.7
CFO To EBITDA
CFO To EBITDA%
16.255.0-34.760.1405.1100.2226.3

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7,4707,33512,828
Price To Earnings
Price To Earnings
21.528.042.8
Price To Sales
Price To Sales
1.81.72.9
Price To Book
Price To Book
2.42.13.9
EV To EBITDA
EV To EBITDA
15.011.119.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
32.732.430.330.832.734.535.635.6
OPM
OPM%
7.28.7-2.58.02.911.312.012.6
NPM
NPM%
1.84.5-6.82.70.08.35.96.5
ROCE
ROCE%
15.517.6-17.414.70.412.113.713.7
ROE
ROE%
6.013.9-40.313.60.111.37.77.7
ROA
ROA%
2.15.7-8.23.00.08.44.74.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7,4707,33512,828
Price To Earnings
Price To Earnings
21.528.042.8
Price To Sales
Price To Sales
1.81.72.9
Price To Book
Price To Book
2.42.13.9
EV To EBITDA
EV To EBITDA
15.011.119.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
32.732.430.330.832.734.535.635.6
OPM
OPM%
7.28.7-2.58.02.911.312.012.6
NPM
NPM%
1.84.5-6.82.70.08.35.96.5
ROCE
ROCE%
15.517.6-17.414.70.412.113.713.7
ROE
ROE%
6.013.9-40.313.60.111.37.77.7
ROA
ROA%
2.15.7-8.23.00.08.44.74.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Akums Drugs & Pharmaceuticals Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/n4wnqvcfgleekaasnpjurfyn.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/faf1qhv4l24etbfnrrla14lt.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/ni66y4m56oo9sekt96mbjlqk.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/v2ims487dt3kmobepuo3rvpa.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/dos1lz9h8518f8rc0ztynwti.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/otup9a5p7c1qaddzemy2d4gg.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/xhk981g0wobac7hlw3wjq4bg.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/p7r58j2kcghkrhpt1box9dpm.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/81t54vhwojwmxy4a7ndif24q.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/ufcfan2a1qtfq0rfcucngipz.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/0wj0eg5czwactnevurcejt02.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/n1xxz8s5x7j0xbxa5i7ecdig.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/xby7evlut3r2u3ttgg32vkhi.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/xwkphjimtl5t1i3rzajhz1c1.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/64ebpwmpoqjtsnw4qmptqh7o.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/xlm5oefr80wwtap4cwsyf8yn.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/hsg9olxko14wqupe9j0f0nw0.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/r2tgggwz4jtxoinjbg3a08xk.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/r41o26xn8w8xw72upumvacd3.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/fyidi5ozv2anbbkwov57kfle.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/3mcvwi9h77z44cy0whl9zc3e.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/wg7yv5ks50w4g0h9aw14h7s7.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/b10jdz0jpnlxe37ch48omeu7.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/o4eskj4zuwi71nk4grss0097.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/6kd82rb9mfmlcgk53x30xibf.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/xnsc76072e7rwyuchemm591f.pdf

Concall Transcript Summaries — Akums Drugs & Pharmaceuticals Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AAKUMS/transcript-notes/202606/n4wnqvcfgleekaasnpjurfyn.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AAKUMS/transcript-notes/202603/faf1qhv4l24etbfnrrla14lt.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AAKUMS/transcript-notes/202512/ni66y4m56oo9sekt96mbjlqk.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AAKUMS/transcript-notes/202509/v2ims487dt3kmobepuo3rvpa.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AAKUMS/transcript-notes/202503/dos1lz9h8518f8rc0ztynwti.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AAKUMS/transcript-notes/202412/otup9a5p7c1qaddzemy2d4gg.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AAKUMS/transcript-notes/202409/xhk981g0wobac7hlw3wjq4bg.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3AAKUMS/transcript-notes/202406/p7r58j2kcghkrhpt1box9dpm.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies